Jump to content

Drilldown: Medicines

Nav

Choose a table:

Medicines (732)

Medicines > classes: [[:Category:Anti-dementia medicines|Anti-dementia medicine]]

& routes

: Oral

or oral paste

Use the filters below to narrow your results.

Donepezil (1) · Memantine (1)

Aricept (oral), Adlarity (transdermal patch) (1) · Namenda (IR), Namenda XR (extended-release), Namzaric (with donepezil) (1)

None (2)

'"`UNIQ--vote-00000017-QINU`"', '"`UNIQ--vote-00000018-QINU`"', '"`UNIQ--vote-00000019-QINU`"', '"`UNIQ--vote-0000001A-QINU`"' (2)

5 mg PO once daily at bedtime; titrate to 10 mg/day after 4-6 weeks. Severe Alzheimer disease: may escalate to 23 mg/day. Adlarity patch: 5 or 10 mg/day applied weekly (1) · 5 mg PO once daily; titrate by 5 mg weekly to target 10 mg PO BID. XR formulation: 7 mg/day, titrate to 28 mg/day (1)

IR tablets 5, 10 mg; oral solution 2 mg/mL; XR capsules 7, 14, 21, 28 mg (1) · Oral tablets 5, 10, 23 mg; ODT 5, 10 mg; Adlarity transdermal patch 5, 10 mg/day (weekly application) (1)

20 mg/day (IR); 28 mg/day (XR) (1) · 23 mg/day (1)

Cognitive effect emerges gradually over weeks to months; ceiling effect at the therapeutic dose (1) · Cognitive effect emerges gradually over weeks to months; symptomatic effect only (1)

24 hours (once-daily dosing) (1) · BID dosing for IR; once-daily for XR (1)

60-100 hours (long)'"`UNIQ--ref-0000001B-QINU`"' (1) · ~70 hours (long, supports once-daily dosing without peak-trough variation)'"`UNIQ--ref-0000001B-QINU`"' (1)

~100% (oral)'"`UNIQ--ref-0000001C-QINU`"' (2)

Limited human data; rarely indicated in pregnancy given the patient population.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> (2)

[[USLegal:Prescription only|Rx-only]] in US (2)

Showing below up to 2 results in range #1 to #2.

D

Donepezil

M

Memantine

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"